14158 Results (Page 445 of 567)
All Market Research Reports
Vietnam Patient Engagement Solutions Market Analysis
Vietnam's patient engagement solutions market is projected to grow from $85.05 Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022-30. The main factors driving the growth would be increasing healthcare spending, an aging population, and government support. The market is segmented by component, delivery mode, application, therapeutic area, functionality, and by end-user. Some of the major players include Oracle, Siemens Healthineers, IBM, and others.
Malaysia Patient Engagement Solutions Market Analysis
Malaysia's patient engagement solutions market is projected to grow from $27.35 Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022-30. The main factors driving the growth would be rising healthcare investments, growing digital health adoption, and government support. The market is segmented by component, delivery mode, application, therapeutic area, functionality, and by end-user. Some of the major players include Nexuses Health, Avanade, Cerner, Wolter Kluwer, and McKesson.
Libya Neurology Devices Market Analysis
The Libya Neurology Device Market is expected to witness growth from $xx Bn in 2022 to $xx Bn in 2030 with a CAGR of xx% for the forecasted year 2022-2030. In Libya, the prevalence of neurological illnesses has grown, which has led to a rise in demand for neurology devices. The market is segmented by product type and by the end user. Some key players in this market include Johnson and Johnson, GE Healthcare, Stryker, Medtronic, Abbott Laboratories and Philips Healthcare.
Finland Patient Engagement Solutions Market Analysis
Finland's patient engagement solutions market is projected to grow from $35.72 Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022-30. The main factors driving the growth would be the growing healthcare sector, advancements in technology, and government support. The market is segmented by component, delivery mode, application, therapeutic area, functionality, and by end-user. Some of the major players include Buddy Healthcare, Tietoevry, Oracle, IBM, and Siemens Healthineers.
Lebanon Neurology Devices Market Analysis
The Lebanon Neurology Device Market is expected to witness growth from $xx Bn in 2022 to $xx Bn in 2030 with a CAGR of xx% for the forecasted year 2022-2030. The prevalence of neurodegenerative diseases like Alzheimer's and Parkinson's disease is rising in Lebanon as the population matures. The demand for Neurology devices, such as diagnostic instruments or brain stimulation devices, may increase as a result of the expanding patient population. The market is segmented by product type and by the end user. Some key players in this market include Johnson and Johnson, GE Healthcare, Stryker, Medtronic, Abbott Laboratories and Philips Healthcare.
Denmark Patient Engagement Solutions Market Analysis
Denmark's patient engagement solutions market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022-30. The main factors driving the growth would be increased adoption of digital health technologies, focus on patient-centered care, government solutions, and a growing aging population. The market is segmented by component, delivery mode, application, therapeutic area, functionality, and by end-user. Some of the major players include Monsenso, OpenTeleHealth, Wolters Kluwer, Oracle, and IBM.
Egypt Neurology Devices Market Analysis
The Egypt Neurology Device Market is expected to witness growth from $35 Mn in 2022 to $72 Mn in 2030 with a CAGR of 9.30% for the forecasted year 2022-2030. There is a rising need for neurology devices in Egypt due to the frequency of neurological disorders such as stroke, epilepsy, Parkinson's disease, and multiple sclerosis. The market is segmented by product type and by the end user. Major Key players in Malaysia's neurology devices market include Wassenburg Medical, EMG-EP Technologies, Johnson and Johnson, GE Healthcare, Stryker, Medtronic and Abbott laboratories.
Algeria Neurology Devices Market Analysis
The Algeria Neurology Device Market is expected to witness growth from $25 Mn in 2022 to $xx Mn in 2030 with a CAGR of xx% for the forecasted year 2022-2030. The Prevalence of Neurological illnesses has increased in Algeria, which is increasing the demand for neurology devices. The population is ageing, habits are changing, and there are environmental issues to blame for this. The market is segmented by product type and by the end user. Some key players in this market include: Techno Brain Group, Biodeal Laboratories, Johnson and Johnson, GE Healthcare, Stryker, Medtronic and Abbott laboratories
Malaysia Connected Healthcare Market Analysis
The Malaysia-connected healthcare market is projected to grow from $106.69 Mn in 2022 to $798.09 Mn by 2030, registering a CAGR of 28.6% during the forecast period of 2022 - 2030. The main factors driving the growth would be increasing healthcare spending, the ageing population, high smartphone penetration and government support. The market is segmented by type, function and by application. Some of the major players include IHH Healthcare Berhad, Zuellig Pharma, Qualitas Medical Group, Siemens Healthineer, GE Healthcare and Medtronic.
UAE Anemia Drugs Market Analysis
The UAE Anemia drugs market was valued at $80 Mn in 2022 and is estimated to expand at a CAGR of 9.9% from 2022-30 and will reach $170 Mn in 2030. One of the main reasons propelling the growth of this market is the introduction of newer technologies, and the aging population. The market is segmented by type, drug, and distribution channel. Some key players in this market are Life Pharma, Neo Pharma, New Bridge Pharmaceuticals, Sahara pharmaceutical, GlaxoSmithKline, GlycoMimetics, and Amgen among others.
Japan Connected Healthcare Market Analysis
The Japan-connected healthcare market is projected to grow from $4.13 Bn in 2022 to $31.44 Bn by 2030, registering a CAGR of 28.9% during the forecast period of 2022 - 2030. The main factors driving the growth would be the ageing population, shortage of healthcare workers, technological innovation and government support. The market is segmented by type, function and by application. Some of the major players include Sony, Hitachi, Fujitsu Limited, Apple, Cisco Systems, IBM and GE Healthcare.
Germany Connected Healthcare Market Analysis
The Germany-connected healthcare market is projected to grow from $2.43 Bn in 2022 to $16.03 Bn by 2030, registering a CAGR of 26.6% during the forecast period of 2022 - 2030. The main factors driving the growth would be the ageing population, strong healthcare infrastructure, research and development infrastructure and government support. The market is segmented by type, function and by application. Some of the major players include Siemens Healthineers, Fresenius Medical Care, CompuGroup Medical, Telekom Healthcare Solutions, Philips Healthcare, IBM, Medtronic, Apple and Honeywell.
Japan Anemia Drugs Market Analysis
Japan's Anemia drugs market was valued at $993 Mn in 2022 and is estimated to expand at a CAGR of 9.40% from 2022-30 and will reach $2038 Mn in 2030. One of the main reasons propelling the growth of this market is the introduction of newer technologies, and the aging population. The market is segmented by type, drug, and distribution channel. Some key players in this market are Pfizer, Astellas Pharma, Takeda Pharmaceutical, Daiichi Sankyo Company, Chugai Pharmaceutical, Otsuka Holdings, Roche, and GSK among others.
Canada Anemia Drugs Market Analysis
Canada's Anemia drugs market was valued at $1.28 Bn in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of 8.9% from 2022 to 2030 and will reach $2.53 Bn in 2030. One of the main reasons propelling the growth of this market is introduction of newer technologies, aging population. The market is segmented by type, drug and distribution channel. Some key players in this market are, Amgen, Roche, Takeda Pharmaceutical, Sanofi, and Novartis among others.
Vietnam Neurology Clinical Trials Market Analysis
The Vietnam Neurology Clinical Trials market is projected to grow from $26.2 Mn in 2022 to $40.8 Mn by 2030, registering a CAGR of 5.73% during the forecast period of 2022 - 2030. The market will be driven by the rising frequency of neurological illnesses such as Alzheimer's, Parkinson's, and stroke along with improving healthcare infrastructure in Vietnam. The market is segmented by phase, by study design & by indication. Some of the major players include Biogen, Pfizer Inc. & Vietnam Pharmaceutical Corporation.
UK Neurology Clinical Trials Market Analysis
The UK Neurology Clinical Trials market is projected to grow from $342.2 Mn in 2022 to $451.4 Mn by 2030, registering a CAGR of 3.52% during the forecast period of 2022 - 2030. The market will be driven by increasing funding and assistance from institutions such as the NIHR as well as greater awareness and understanding of neurological disorders. The market is segmented by phase, by study design & by indication. Some of the major players include Pfizer Inc., Biogen Inc & Cambridge Cognition Holdings PLC.
France Artificial Intelligence (AI) in Medical Imaging Market Analysis
France artificial intelligence (AI) in medical Imaging market size was valued at $41 Mn in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of 34.4% from 2022 to 2030 and will reach $439 Mn. The market is segmented by AI technology, solution, modality, application, and end User. Due to developments in AI and machine learning algorithms that are enabling the creation of more precise and effective medical imaging software, the France Artificial Intelligence (AI) in the Medical Imaging market will expand. Some of the key players in this market are KineQuantum, Quantificare, Median Technologies, Mirada Medical, CureMetrix, Olea Medical, Aidence, Smart Reporting, CorTechs Labs, and others, and others.
India Artificial Intelligence (AI) in Medical Imaging Market Analysis
India artificial intelligence (AI) in medical Imaging market size was valued at $27 Mn in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of 38.4% from 2022 to 2030 and will reach $367 Mn. The market is segmented by AI technology, solution, modality, application, and end User. Due to developments in AI and machine learning algorithms that are enabling the creation of more precise and effective medical imaging software, the India Artificial Intelligence (AI) in the Medical Imaging market will expand. Some of the key players in this market Niramai Health Analytix, Qure.ai, Predible Health, 4C Medical Technologies, Perfint Healthcare, GE Healthcare, Siemens Healthineers, Philips Healthcare, Fujifilm India and others.
Germany Artificial Intelligence (AI) in Medical Imaging Market Analysis
The Germany Artificial Intelligence (AI) in Medical Imaging market size was valued at $55 Mn in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of 33.6% from 2022 to 2030 and will reach $557 Mn. The market is segmented by AI technology, solution, modality, application, and end User. The Germany Artificial Intelligence (AI) in the Medical Imaging market will grow due to advances in AI and machine learning algorithms that are making it possible to develop more accurate and efficient medical imaging software. Some of the key players in this market are Siemens Healthineers, Philips Healthcare, Agfa-Gevaert Group, Canon Medical Systems, Fujifilm, and others.
Turkey Neurology Clinical Trials Market Analysis
The Turkey Neurology Clinical Trials market is projected to grow from $41.8 Mn in 2022 to $66.7 Mn by 2030, registering a CAGR of 6% during the forecast period of 2022 - 2030. The market will be driven by the rising frequency of neurological illnesses such as Alzheimer's, Parkinson's, and stroke and rising investment in research facilities. The market is segmented by phase, by study design & by indication. Some of the major players include Pfizer Inc., Novartis AG & Abdi İbrahim.
Thailand Neurology Clinical Trials Market Analysis
The Thailand Neurology Clinical Trials market is projected to grow from $6.28 Mn in 2022 to $9.88 Mn by 2030, registering a CAGR of 5.84% during the forecast period of 2022 - 2030. The market will be driven by the country's favourable regulatory environment, big patient pool, and highly qualified medical professionals. The market is segmented by phase, by study design & by indication. Some of the major players include Novartis International AG, Pfizer Inc. & Siam Bioscience Co., Ltd.
Spain Neurology Clinical Trials Market Analysis
The Spain Neurology Clinical Trials market is projected to grow from $100.9 Mn in 2022 to $143.5 Mn by 2030, registering a CAGR of 4.5% during the forecast period of 2022 - 2030. The market will be driven by well-established infrastructure, skilled researchers, and access to a big patient population. The market is segmented by phase, by study design & by indication. Some of the major players include Pfizer Inc, Grifols, S.A. & Almirall, S.A.
South Korea Neurology Clinical Trials Market Analysis
The South Korea Neurology Clinical Trials market is projected to grow from $76.4 Mn in 2022 to $126.5 Mn by 2030, registering a CAGR of 6.5% during the forecast period of 2022 - 2030. The market will be driven by the supportive regulatory environment and increasing interest from pharmaceutical companies investing in neurology clinical trials. The market is segmented by phase, by study design & by indication. Some of the major players include Hoffmann-La Roche, Biogen & Chong Kun Dang Pharmaceutical.
APAC Anemia Drugs Market Analysis
The APAC Anemia drugs market was valued at $3.36 Bn in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of 10.17% from 2022 to 2030 and will reach $7.28 Bn in 2030. One of the main reasons propelling the growth of this market is the rising prevalence of chronic kidney disease and the aging population. The market is segmented by type, drug, and distribution channel. Some key players in this market are Amgen, Bayer AG, Takeda Pharmaceutical, GlaxoSmithKline, Johnson, and Johnson, Pfizer, and Novartis.
Singapore Neurology Clinical Trials Market Analysis
The Singapore Neurology Clinical Trials market is projected to grow from $6.28 Mn in 2022 to $10.08 Mn by 2030, registering a CAGR of 6.1% during the forecast period of 2022 - 2030. The market will be driven by investments in clinical research and fostering collaborations between researchers, healthcare professionals, and industry partners. The market is segmented by phase, by study design & by indication. Some of the major players include Novartis International AG, Biogen & Invitrocue Pte Ltd.
